Evidence map›Paper›PMID 36692307›Full record

ArticleAntimicrobial agents and chemotherapy2023

Pharmacodynamics of Temocillin in Neutropenic Murine Infection Models.

Anouk E Muller, Merel Raaphorst, Aart van der Meijden, Brenda C M de Winter, Joseph Meletiadis, Sanne van den Berg

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anouk E MullerDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0001-5042-6251
Merel RaaphorstDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Aart van der MeijdenDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Brenda C M de WinterCATOR, Center for Antimicrobial Optimized Treatment-Rotterdam, Rotterdam, The Netherlands.
Joseph MeletiadisDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-8869-1509
Sanne van den BergDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Temocillin is used for the treatment of various infections caused by

Indexed as

Communicable DiseasesNeutropeniaAnimalsAnti-Bacterial AgentsEscherichia coliKlebsiella pneumoniaeLungMiceMicrobial Sensitivity TestsPenicillinsThighAnti-Bacterial AgentsPenicillinstemocillinefficacypharmacodynamicsPK/PD index

Identifiers

PMID36692307
PMCPMC9933716
OpenAlexW4317871356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.